The CD8+ T cell proliferation half-lives and tumor carrying capacities do not significantly differ between responders and non-responders across studies (p-values are unadjusted, significance threshold is 0.05/3 = 0.016 with Bonferroni correction), potentially due to the high shrinkage values (Table 2). This evidence concerns the gene CD8A and neoplasm.